Long-term Response of Helicobacter pylori Antibody Titer After Eradication Treatment in Middle-aged Japanese: JPHC-NEXT Study

BACKGROUND: Helicobacter pylori (H. pylori) is an established causative factor of gastric cancer. Although the expansion of insurance coverage has led to an increase in the number of patients treated for H. pylori, the population impact of eradication treatment for H. pylori has been scarcely invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Shiori, Goto, Atsushi, Yamagishi, Kazumasa, Iwasaki, Motoki, Yamaji, Taiki, Shimazu, Taichi, Iso, Hiroyasu, Muraki, Isao, Yasuda, Nobufumi, Saito, Isao, Kato, Tadahiro, Aoyagi, Kiyoshi, Arima, Kazuhiko, Sakata, Kiyomi, Tanno, Kozo, Inoue, Manami, Sawada, Norie, Tsugane, Shoichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Epidemiological Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727212/
https://www.ncbi.nlm.nih.gov/pubmed/33907066
http://dx.doi.org/10.2188/jea.JE20200618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727212/
https://www.ncbi.nlm.nih.gov/pubmed/33907066
http://dx.doi.org/10.2188/jea.JE20200618

Ejemplares similares